Double Bond Pharmaceutical International AB (XSAT:DBP B) Cyclically Adjusted Book per Share: kr0.25 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:DBP B Double Bond Pharmaceutical International AB XSAT:DBP B
30 GF Score
Price kr0.14
GF Value kr0.06
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Double Bond Pharmaceutical International AB Cyclically Adjusted Book per Share?

Double Bond Pharmaceutical International AB XSAT:DBP B +2.26% 30 Cyclically Adjusted Book per Share is kr0.25 as of Mar. 2026. GuruFocus rates XSAT:DBP B with a GF Score™ of 30/100 and a GF Value™ of kr0.06 (Significantly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Double Bond Pharmaceutical International AB's adjusted book value per share for the three months ended in Mar. 2026 was kr0.068. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr0.25 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Double Bond Pharmaceutical International AB's average Cyclically Adjusted Book Growth Rate was -10.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-21), Double Bond Pharmaceutical International AB's current stock price is kr0.1355. Double Bond Pharmaceutical International AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr0.25. Double Bond Pharmaceutical International AB's Cyclically Adjusted PB Ratio of today is 0.54.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Double Bond Pharmaceutical International AB was 1.58. The lowest was 0.37. And the median was 0.49.


Double Bond Pharmaceutical International AB  (XSAT:DBP B) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Double Bond Pharmaceutical International AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.1355/0.25
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Double Bond Pharmaceutical International AB was 1.58. The lowest was 0.37. And the median was 0.49.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Double Bond Pharmaceutical International AB Cyclically Adjusted Book per Share Related Terms


Double Bond Pharmaceutical International AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Double Bond Pharmaceutical International AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Double Bond Pharmaceutical International AB Cyclically Adjusted Book per Share Chart

Double Bond Pharmaceutical International AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.29 0.25

Double Bond Pharmaceutical International AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.27 0.27 0.25 0.25

XSAT:DBP B vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Double Bond Pharmaceutical International AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Double Bond Pharmaceutical International AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Double Bond Pharmaceutical International AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Double Bond Pharmaceutical International AB's Cyclically Adjusted PB Ratio falls into.


XSAT:DBP B
30GF Score
Double Bond Pharmaceutical International AB XSAT:DBP B
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Double Bond Pharmaceutical International AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Double Bond Pharmaceutical International AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.068/133.5600*133.5600
=0.068

Current CPI (Mar. 2026) = 133.5600.

Double Bond Pharmaceutical International AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.073 101.019 0.097
201609 0.485 101.138 0.640
201612 0.824 102.022 1.079
201703 0.222 102.022 0.291
201706 0.215 102.752 0.279
201709 0.051 103.279 0.066
201712 0.013 103.793 0.017
201803 -0.039 103.962 -0.050
201806 0.130 104.875 0.166
201809 0.154 105.679 0.195
201812 0.044 105.912 0.055
201903 0.214 105.886 0.270
201906 0.377 106.742 0.472
201909 0.227 107.214 0.283
201912 0.188 107.766 0.233
202003 0.496 106.563 0.622
202006 0.419 107.498 0.521
202009 0.430 107.635 0.534
202012 0.330 108.296 0.407
202103 0.281 108.360 0.346
202106 0.341 108.928 0.418
202109 0.360 110.338 0.436
202112 0.363 112.486 0.431
202203 0.360 114.825 0.419
202206 0.327 118.384 0.369
202209 0.287 122.296 0.313
202212 0.160 126.365 0.169
202303 0.145 127.042 0.152
202306 0.159 129.407 0.164
202309 0.131 130.224 0.134
202312 0.056 131.912 0.057
202403 0.064 132.205 0.065
202406 0.035 132.716 0.035
202409 0.026 132.304 0.026
202412 0.037 132.987 0.037
202503 0.027 132.825 0.027
202506 0.023 133.699 0.023
202509 0.056 133.480 0.056
202512 0.069 133.390 0.069
202603 0.068 133.560 0.068

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr0.25 mean?
Double Bond Pharmaceutical International AB (XSAT:DBP B) has a Cyclically Adjusted Book per Share of kr0.25 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Double Bond Pharmaceutical International AB and its competitors.
Is Double Bond Pharmaceutical International AB's Cyclically Adjusted Book per Share too high?
Double Bond Pharmaceutical International AB's current Cyclically Adjusted Book per Share is kr0.25. Overall, Double Bond Pharmaceutical International AB has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Double Bond Pharmaceutical International AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Double Bond Pharmaceutical International AB's Cyclically Adjusted Book per Share of kr0.25 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Double Bond Pharmaceutical International AB and its competitors. Double Bond Pharmaceutical International AB's current Cyclically Adjusted Book per Share is kr0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Double Bond Pharmaceutical International AB stock overvalued right now?
Based on GuruFocus' analysis, Double Bond Pharmaceutical International AB (XSAT:DBP B) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.06, compared to a current price of kr0.14 — trading 125.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is kr0.25. Double Bond Pharmaceutical International AB's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Double Bond Pharmaceutical International AB (XSAT:DBP B), the current Cyclically Adjusted Book per Share is kr0.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Double Bond Pharmaceutical International AB (XSAT:DBP B) Overvalued in 2026?

Based on GuruFocus' analysis, Double Bond Pharmaceutical International AB stock appears to be overvalued. The current stock price of kr0.14 is trading 125.8% above its estimated GF Value™ of kr0.06. GuruFocus considers Double Bond Pharmaceutical International AB to be Significantly Overvalued.

Key valuation signals for XSAT:DBP B:

  • Cyclically Adjusted Book per Share: kr0.25
  • GF Value™: kr0.06 vs. price of kr0.14 (125.8% above fair value)
  • GF Score™: 30/100 with 3 warning signs

No single metric tells the full story. See the XSAT:DBP B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Double Bond Pharmaceutical International AB Business Description

Address Virdings Alle 32B, Uppsala, SWE, 75450
Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.
30GF Score

Get the complete analysis for XSAT:DBP B

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.14
Price
kr0.06
GF Value